Evidence map›Paper›PMID 19301657›Full record

ReviewMethods in molecular biology (Clifton, N.J.)2009

Protein components of the microRNA pathway and human diseases.

Marjorie P Perron, Patrick Provost

Open access · greenAbstract readReview
In one paragraph

Review in Methods in molecular biology (Clifton, N.J.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Non-coding RNAs and the mineralocorticoid receptor in the kidney.Molecular and cellular endocrinology · 2021
    Review
  5. Pigmy MicroRNA: surveillance cops in Therapies kingdom.Molecular medicine (Cambridge, Mass.) · 2016
    Article
  6. The Function of TrophomiRs and Other MicroRNAs in the Human Placenta.Cold Spring Harbor perspectives in medicine · 2015
    Review
  7. MicroRNAs and the regulation of aldosterone signaling in the kidney.American journal of physiology. Cell physiology · 2015
    Review
  8. Fragile X-associated tremor/ataxia syndrome.Annals of the New York Academy of Sciences · 2015
    Review
  9. Article
  10. Review
  11. Article
  12. Human RNAi pathway: crosstalk with organelles and cells.Functional & integrative genomics · 2014
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. MicroRNAs in common human diseases.Genomics, proteomics & bioinformatics · 2012
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Marjorie P PerronCentre de Recherche en Rhumatologie et Immunologie, CHUL Research Center, Quebec, Canada.
Patrick Provost

Funding

CIHR 69151
6 · The paper itself

Abstract

MicroRNAs (miRNAs) are key regulators of messenger RNA (mRNA) translation known to be involved in a wide variety of cellular processes. In fact, their individual importance is reflected in the diseases that may arise upon the loss, mutation or dysfunction of specific miRNAs. It has been appreciated only recently that diseases may also develop when the protein components of the miRNA machinery itself are affected. The core enzymes of the major protein complexes involved in miRNA biogenesis and function, such as the ribonucleases III (RNases III) Drosha and Dicer as well as Argonaute 2 (Ago2), appear to be essential. However, the accessory proteins of the miRNA pathway, such as the DiGeorge syndrome critical region gene 8 (DGCR8) protein, Exportin-5 (Exp-5), TAR RNA binding protein (TRBP) and fragile X mental retardation protein (FMRP), are each related, in various ways, to specific genetic diseases.

Indexed as

Gene SilencingGenetic Diseases, InbornHumansMicroRNAsProteinsMicroRNAsProteins

Identifiers

PMID19301657
PMCPMC2903565
OpenAlexW1481377573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.